| 000 | 01372 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517230029.0 | ||
| 264 | 0 | _c20190715 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1479-6821 | ||
| 024 | 7 |
_a10.1530/ERC-18-0082 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrincipe, M | |
| 245 | 0 | 0 |
_aALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation. _h[electronic resource] |
| 260 |
_bEndocrine-related cancer _c09 2018 |
||
| 300 |
_a795-806 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActivin Receptors, Type I _xmetabolism |
| 650 | 0 | 4 |
_aActivins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPituitary Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aProlactin _xmetabolism |
| 650 | 0 | 4 |
_aProlactinoma _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aChanal, M | |
| 700 | 1 | _aKaram, V | |
| 700 | 1 | _aWierinckx, A | |
| 700 | 1 | _aMikaélian, I | |
| 700 | 1 | _aGadet, R | |
| 700 | 1 | _aAuger, C | |
| 700 | 1 | _aRaverot, V | |
| 700 | 1 | _aJouanneau, E | |
| 700 | 1 | _aVasiljevic, A | |
| 700 | 1 | _aHennino, A | |
| 700 | 1 | _aRaverot, G | |
| 700 | 1 | _aBertolino, P | |
| 773 | 0 |
_tEndocrine-related cancer _gvol. 25 _gno. 9 _gp. 795-806 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/ERC-18-0082 _zAvailable from publisher's website |
| 999 |
_c28636818 _d28636818 |
||